Skip to main content
Article thumbnail
Location of Repository

In Silico Whole Genome Association Scan for Murine Prepulse Inhibition

By Bradley Todd Webb, Joseph L. McClay, Cristina Vargas-Irwin, Timothy P. York and Edwin J. C. G. van den Oord
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2004). A collaborative database of inbred mouse strain characteristics.
    2. (2003). A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia.
    3. (2004). A new set of BXD recombinant inbred lines from advanced intercross populations in mice.
    4. (2006). A QTL on rat chromosome 7 modulates prepulse inhibition, a neurobehavioral trait of ADHD, in a Lewis x SHR intercross.
    5. (2008). Accounting for ancestry: population substructure and genome-wide association studies.
    6. (2003). Acoustic startle and prepulse inhibition in 40 inbred strains of mice.
    7. (1998). Acoustic startle, prepulse inhibition, locomotion, and latent inhibition in the neurolepticresponsive (NR) and neuroleptic-nonresponsive (NNR) lines of mice.
    8. (2004). An efficient SNP system for mouse genome scanning and elucidating strain relationships.
    9. (2004). Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.
    10. (2004). Association between chromogranin b gene polymorphisms and schizophrenia in the Japanese population.
    11. (2005). Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population.
    12. (2005). Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory.
    13. (2004). Association of the DTNBP1 locus with schizophrenia in a U.S. population.
    14. (2006). Behavioral and neurochemical alterations in mice lacking the RNA-binding protein translin.
    15. (2004). Betting odds and genetic associations.
    16. (2000). Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia.
    17. (2003). Comparison of methods for estimating the number of true null hypotheses in multiplicity testing.
    18. (2005). Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function.
    19. (2005). Controlling false discoveries in candidate gene studies.
    20. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing.
    21. (2004). Controlling the number of false discoveries: application to high-dimensional genomic data.
    22. (2004). Controlling the proportion of false positives in multiple dependent tests.
    23. (2003). Differential effects of phencyclidine application on secretogranin II expression in organotypic slices of rat prefrontal cortex.
    24. (2001). Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment.
    25. (2002). Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation.
    26. (2009). ERGR: An ethanol-related gene resource.
    27. (2001). Estimating effects of latent and measured genotypes in multilevel models.
    28. (2003). Estimation of false discovery rates in multiple testing: application to gene microarray data.
    29. (2003). Evolution’s cauldron: duplication, deletion, and rearrangement in the mouse and human genomes.
    30. (2005). Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia.
    31. (2007). Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype.
    32. (2003). False discoveries and models for gene discovery.
    33. (2003). False discovery rate in linkage and association genome screens for complex disorders.
    34. (2003). Family-based association study of DTNBP1 in 6p22.3 and schizophrenia.
    35. (2000). Genealogies of mouse inbred strains.
    36. (2003). Genetic influences on prepulse inhibition of startle reflex in humans.
    37. (2004). Genetic structure of the LXS panel of recombinant inbred mouse strains: a powerful resource for complex trait analysis.
    38. (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.
    39. (1997). Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition.
    40. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.
    41. (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.
    42. (2005). Heritability, correlations and in silico mapping of locomotor behavior and neurochemistry in inbred strains of mice.
    43. (2004). Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
    44. (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.
    45. (2004). Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).
    46. (2003). Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.
    47. (2003). Identification of quantitative trait loci for prepulse inhibition in rats.
    48. (2005). Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations.
    49. (2004). In silico genetics: identification of a functional element regulating H2-Ealpha gene expression.
    50. (2001). In silico mapping of complex disease-related traits in mice.
    51. (2001). In silico mapping of mouse quantitative trait loci.
    52. (2003). In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice.
    53. (2003). Inappropriate choice of the experimental unit leads to a dramatic overestimation of the significance of quantitative trait loci for prepulse inhibition and startle response in recombinant congenic mice.
    54. (1999). LOD significance thresholds for QTL analysis in experimental populations of diploid species.
    55. (1997). Methods correcting for multiple testing: Operating characteristics.
    56. (2008). Model-based gene selection shows engrailed 1 is associated with antipsychotic response.
    57. (2000). Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits.
    58. (1995). Multilevel statistical models.
    59. (2003). Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes.
    60. (1999). On the relationships of highfrequency hearing loss and cochlear pathology to the acoustic startle response (ASR) and prepulse inhibition of the ASR in the BXD recombinant inbred series.
    61. (2005). Partial reversal of phencyclidine-induced impairment of prepulse inhibition by secretin.
    62. (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.
    63. (2002). Polymorphisms of chromogranin B gene associated with schizophrenia in Chinese Han population.
    64. (2008). Prepulse inhibition (PPI) of tactile startle response in recombinant congenic strains of mice: QTL mapping and comparison with acoustic PPI.
    65. (2002). Provisional mapping of quantitative trait loci modulating the acoustic startle response and prepulse inhibition of acoustic startle.
    66. (2003). Reply: Inappropriate Choice of the Experimental Unit Leads to a Dramatic Overestimation of the Significance of Quantitative Trait Loci for Prepulse Inhibition and Startle Response in Recombinant Congenic Mice.
    67. (2008). Short-term selective breeding for high and low prepulse inhibition of the acoustic startle response; pharmacological characterization and QTL mapping in the selected lines.
    68. (2006). Significant linkage and association between a functional (GT)n polymorphism in promoter of the Nmethyl-d-aspartate receptor subunit gene (GRIN2A) and schizophrenia.
    69. (2004). Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria.
    70. (2003). Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families.
    71. (2003). The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease.
    72. (2001). The genetic structure of recombinant inbred mice: high-resolution consensus maps for complex trait analysis.
    73. (2002). The human genome browser at UCSC.
    74. (2002). The mosaic structure of variation in the laboratory mouse genome.
    75. (2003). The positive false discovery rate: A Bayesian interpretation and the q-value.
    76. (2004). The relative levels of translin-associated factor X (TRAX) and testis brain RNAbinding protein determine their nucleocytoplasmic distribution in male germ cells.
    77. (2005). Two QTLs for prepulse inhibition of startle identified on mouse chromosome 16 using chromosome substitution strains.
    78. (2004). Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse.
    79. (1992). Variance components.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.